Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension

por Wang, Huai-yu, Peng, Suyuan, Ye, Zhanghui, Li, Pengfei, Li, Qing, Shi, Xuanyu, Zeng, Rui, Yao, Ying, He, Fan, Li, Junhua, Liu, Liu, Ge, Shuwang, Ke, Xianjun, Zhou, Zhibin, Xu, Gang, Zhao, Ming-hui, Wang, Haibo, Zhang, Luxia, Dong, Erdan
Publicado 2021